Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer

He Huang, Caiping Nie, Xiufeng Liu, +20

Journal of Clinical Investigation

A randomized, double-blinded, phase III study of icaritin versus huachashu as the first-line therapy in biomarker-enriched HBV-related advanced hepatocellular carcinoma with poor conditions: Interim analysis result.

Yan Sun, Shukui Qin, Wei Li, +16

Journal of Clinical Oncology

Chemoprevention StrategyImmunologyImmune RegulationPathologyIcaritin Versus Huachashu +20

Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer

Jiujie Cui, Jiao Feng, Qi Li, +46

Journal of the National Cancer Center

Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota

Canye Li, Zuanjun Su, Zhicong Chen, +3

Frontiers in Pharmacology

Cyclohexane oxidation over AFI molecular sieves: effects of Cr, Co incorporation and crystal size

Decheng Liu, Baoquan Zhang, Xiufeng Liu, +1

Catalysis Science & Technology

EngineeringOxidation ResistanceMild ConditionsOrganic ChemistryChemistry +14

Updated analysis with longer follow up of a phase 2a study evaluating erdafitinib in Asian patients (pts) with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor (FGFR) alterations.

Yin‐Hsun Feng, Wu‐Chou Su, Do‐Youn Oh, +9

Journal of Clinical Oncology

PathologyPharmacotherapyOncologyGastrointestinal OncologyHepatobiliary Tumor +17

Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective

Xia Zheng, Bin Ye, Yudong Gou, +5

Translational Cancer Research

A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients

Yu-Jing Liang, Qiuyan Chen, Jing-xiao Xu, +18

European Journal of Cancer

Lymphoid NeoplasiaPhase IiMedicineImmunologyAdjuvant Tumour-infiltrating Lymphocytes +6

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Joon Oh Park, Yin‐Hsun Feng, Wu‐Chou Su, +12

BMC Cancer

Day surgery management model in china: practical experience and initial evaluation.

Huiyong Jiang, Junyi Han, Aiguo Lu, +1

PubMed